Controlled drug delivery in tissue engineering.

The concept of tissue and cell guidance is rapidly evolving as more information regarding the effect of the microenvironment on cellular function and tissue morphogenesis become available. These disclosures have lead to a tremendous advancement in the design of a new generation of multifunctional biomaterials able to mimic the molecular regulatory characteristics and the three-dimensional architecture of the native extracellular matrix. Micro- and nano-structured scaffolds able to sequester and deliver in a highly specific manner biomolecular moieties have already been proved to be effective in bone repairing, in guiding functional angiogenesis and in controlling stem cell differentiation. Although these platforms represent a first attempt to mimic the complex temporal and spatial microenvironment presented in vivo, an increased symbiosis of material engineering, drug delivery technology and cell and molecular biology may ultimately lead to biomaterials that encode the necessary signals to guide and control developmental process in tissue- and organ-specific differentiation and morphogenesis.

[1]  J L Cleland,et al.  Development of a single-shot subunit vaccine for HIV-1. 2. Defining optimal autoboost characteristics to maximize the humoral immune response. , 1996, Journal of pharmaceutical sciences.

[2]  Samuel I Stupp,et al.  Simultaneous self-assembly, orientation, and patterning of peptide-amphiphile nanofibers by soft lithography. , 2007, Nano letters.

[3]  Filippo Causa,et al.  Bioactive scaffolds for bone and ligament tissue , 2007, Expert review of medical devices.

[4]  N. Peppas,et al.  Poly(ethylene glycol)-containing hydrogels in drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Diane J Burgess,et al.  Pharmacokinetic characterization of 14C‐vascular endothelial growth factor controlled release microspheres using a rat model , 2002, The Journal of pharmacy and pharmacology.

[6]  R. Gurny,et al.  Release of BSA from poly(ortho ester) extruded thin strands. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Richard B. Dickinson,et al.  Quantitative Analysis of Adhesion-Mediated Cell Migration in Three-Dimensional Gels of RGD-Grafted Collagen , 2004, Annals of Biomedical Engineering.

[8]  Gabriela A Silva,et al.  Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. , 2007, Advanced drug delivery reviews.

[9]  J. Mcdonald,et al.  Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[10]  P. Gupta,et al.  Hydrogels: from controlled release to pH-responsive drug delivery. , 2002, Drug discovery today.

[11]  A. Metters,et al.  Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Sweta Modi,et al.  Role of polyanhydrides as localized drug carriers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[13]  David J. Mooney,et al.  DNA delivery from polymer matrices for tissue engineering , 1999, Nature Biotechnology.

[14]  Hans P. Merkle,et al.  Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres : importance of polymer degradation and antigen release for immune response , 1996 .

[15]  Sven Frokjaer,et al.  Factors of importance for a successful delivery system for proteins , 2005, Expert opinion on drug delivery.

[16]  R. Langer,et al.  Designing materials for biology and medicine , 2004, Nature.

[17]  Hiroyuki Honda,et al.  Transglutaminase-mediated gelatin matrices incorporating cell adhesion factors as a biomaterial for tissue engineering. , 2003, Journal of bioscience and bioengineering.

[18]  O Damour,et al.  A tissue‐engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary‐like tube formation in vitro , 2003, The British journal of dermatology.

[19]  Alessandra Pavesio,et al.  Epidermal homeostasis in long-term scaffold-enforced skin equivalents. , 2006, The journal of investigative dermatology. Symposium proceedings.

[20]  L. Meinel,et al.  Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[21]  J. Pachence,et al.  Collagen-based devices for soft tissue repair. , 1996, Journal of biomedical materials research.

[22]  Ralph Müller,et al.  Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. , 2006, Biomacromolecules.

[23]  J L Cleland,et al.  Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. , 2001, Journal of pharmaceutical sciences.

[24]  Paolo A Netti,et al.  The effect of matrix composition of 3D constructs on embryonic stem cell differentiation. , 2005, Biomaterials.

[25]  Indu Bala,et al.  PLGA nanoparticles in drug delivery: the state of the art. , 2004, Critical reviews in therapeutic drug carrier systems.

[26]  M. Shoichet,et al.  Immobilized concentration gradients of neurotrophic factors guide neurite outgrowth of primary neurons in macroporous scaffolds. , 2006, Tissue engineering.

[27]  Dietmar W. Hutmacher,et al.  Evaluation of Ultra-Thin Poly(ε-Caprolactone) Films for Tissue-Engineered Skin , 2001 .

[28]  J Engel,et al.  Laminins and other strange proteins. , 1992, Biochemistry.

[29]  U. Häfeli,et al.  Magnetically modulated therapeutic systems. , 2004, International journal of pharmaceutics.

[30]  W. Saltzman,et al.  Simultaneous delivery of an active protein and neutralizing antibody: creation of separated regions of biological activity. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Lonnie D Shea,et al.  Inductive tissue engineering with protein and DNA-releasing scaffolds. , 2006, Molecular bioSystems.

[32]  G. Whitesides,et al.  Soft lithography in biology and biochemistry. , 2001, Annual review of biomedical engineering.

[33]  Antonios G. Mikos,et al.  Review: Biodegradable Polymeric Scaffolds. Improvements in Bone Tissue Engineering through Controlled Drug Delivery , 2005 .

[34]  Kristi S Anseth,et al.  DNA delivery from photocrosslinked PEG hydrogels: encapsulation efficiency, release profiles, and DNA quality. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[35]  Tae Gwan Park,et al.  Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. , 2007, Advanced drug delivery reviews.

[36]  Suming Li,et al.  Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. , 1995, Biomaterials.

[37]  W M Reichert,et al.  In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings. , 2005, Biomaterials.

[38]  Tatsuo Nakamura,et al.  Slow release of bone morphogenetic protein 2 from a gelatin sponge to promote regeneration of tracheal cartilage in a canine model. , 2004, The Journal of thoracic and cardiovascular surgery.

[39]  P. Sinko,et al.  A hydrogel prepared by in situ cross-linking of a thiol-containing poly(ethylene glycol)-based copolymer: a new biomaterial for protein drug delivery. , 2003, Biomaterials.

[40]  Dietmar W Hutmacher,et al.  Scaffold-based tissue engineering: rationale for computer-aided design and solid free-form fabrication systems. , 2004, Trends in biotechnology.

[41]  Martin Ehrbar,et al.  Cell‐demanded release of VEGF from synthetic, biointeractive cell‐ingrowth matrices for vascularized tissue growth , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  Ick Chan Kwon,et al.  Effects of a chitosan scaffold containing TGF-beta1 encapsulated chitosan microspheres on in vitro chondrocyte culture. , 2004, Artificial organs.

[43]  Daniel Howard,et al.  Zonal release of proteins within tissue engineering scaffolds , 2006, Journal of materials science. Materials in medicine.

[44]  Paolo A. Netti,et al.  The performance of poly-ε-caprolactone scaffolds in a rabbit femur model with and without autologous stromal cells and BMP4 , 2007 .

[45]  A A Poot,et al.  Binding and release of basic fibroblast growth factor from heparinized collagen matrices. , 2001, Biomaterials.

[46]  Peter X Ma,et al.  Pulsatile release of parathyroid hormone from an implantable delivery system. , 2007, Biomaterials.

[47]  Nureddin Ashammakhi,et al.  Topics in Tissue Engineering , 2004 .

[48]  D. Mooney,et al.  Combined Angiogenic and Osteogenic Factor Delivery Enhances Bone Marrow Stromal Cell‐Driven Bone Regeneration , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  M Raspanti,et al.  Hierarchical structures in fibrillar collagens. , 2002, Micron.

[50]  D H Kohn,et al.  Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. , 2000, Biomaterials.

[51]  Hyun Jung Chung,et al.  Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor. , 2006, Journal of biomedical materials research. Part A.

[52]  Seeram Ramakrishna,et al.  Electrospun scaffold tailored for tissue‐specific extracellular matrix , 2006, Biotechnology journal.

[53]  R Langer,et al.  Responsive polymeric delivery systems. , 2001, Advanced drug delivery reviews.

[54]  T. Kissel,et al.  In situ forming parenteral drug delivery systems: an overview. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[55]  R. Gurny,et al.  Therapeutic applications of viscous and injectable poly(ortho esters). , 2001, Advanced drug delivery reviews.

[56]  Tejal A Desai,et al.  Micromachined biocapsules for cell-based sensing and delivery. , 2004, Advanced drug delivery reviews.

[57]  David J Mooney,et al.  Modifying the proliferative state of target cells to control DNA expression and identifying cell types transfected in vivo. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[58]  Jennifer L. West,et al.  Tethered-TGF-β increases extracellular matrix production of vascular smooth muscle cells , 2001 .

[59]  David J. Mooney,et al.  Polymeric Growth Factor Delivery Strategies for Tissue Engineering , 2003, Pharmaceutical Research.

[60]  J. Hubbell,et al.  Development of fibrin derivatives for controlled release of heparin-binding growth factors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[61]  N. Schwartz,et al.  Biosynthesis and regulation of expression of proteoglycans. , 2000, Frontiers in bioscience : a journal and virtual library.

[62]  C. Astete,et al.  Synthesis and characterization of PLGA nanoparticles , 2006, Journal of biomaterials science. Polymer edition.

[63]  Antonios G Mikos,et al.  In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[64]  J Kent Leach,et al.  Multifunctional cell-instructive materials for tissue regeneration. , 2006, Regenerative medicine.

[65]  Yutaka Ikeda,et al.  Ligand-Targeted Delivery of Therapeutic siRNA , 2006, Pharmaceutical Research.

[66]  Lonnie D Shea,et al.  Non-viral vector delivery from PEG-hyaluronic acid hydrogels. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[67]  R. Langer,et al.  Tissue engineering: current state and perspectives , 2004, Applied Microbiology and Biotechnology.

[68]  P. Lemaire,et al.  Activin signalling and response to a morphogen gradient , 1994, Nature.

[69]  Antonios G Mikos,et al.  Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[70]  Jeffrey Bonadio,et al.  Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration , 1999, Nature Medicine.

[71]  Hassan Adwan,et al.  Delivery and expression of pDNA embedded in collagen matrices. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[72]  T. Cheng,et al.  Therapeutic potential of chitosan and its derivatives in regenerative medicine. , 2006, The Journal of surgical research.

[73]  Federica Boschetti,et al.  Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[74]  A. Perets,et al.  Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. , 2003, Journal of biomedical materials research. Part A.

[75]  Paolo A Netti,et al.  Induction of directional sprouting angiogenesis by matrix gradients. , 2007, Journal of biomedical materials research. Part A.

[76]  Glenn D Prestwich,et al.  Vocal fold tissue repair in vivo using a synthetic extracellular matrix. , 2006, Tissue engineering.

[77]  H. Vandenburgh,et al.  Recombinant Vascular Endothelial Growth Factor Secreted From Tissue-Engineered Bioartificial Muscles Promotes Localized Angiogenesis , 2001, Circulation.

[78]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[79]  Byung-Soo Kim,et al.  Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[80]  David J. Mooney,et al.  Spatio–temporal VEGF and PDGF Delivery Patterns Blood Vessel Formation and Maturation , 2007, Pharmaceutical Research.

[81]  J. Tessmar,et al.  Matrices and scaffolds for protein delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[82]  A. Mikos,et al.  Controlled release of transforming growth factor β1 from biodegradable polymer microparticles , 2000 .

[83]  Michael S. Goldberg,et al.  Nanostructured materials for applications in drug delivery and tissue engineering , 2007, Journal of biomaterials science. Polymer edition.

[84]  Tatiana Segura,et al.  Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern. , 2005, Biomaterials.

[85]  K. Alitalo,et al.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.

[86]  Vladimir Volloch,et al.  Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. , 2004, Journal of biomedical materials research. Part A.

[87]  Byung-Soo Kim,et al.  Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold. , 2007, Biomaterials.

[88]  J L Cleland,et al.  Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[89]  Heungsoo Shin,et al.  Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. , 2007, Advanced drug delivery reviews.

[90]  Yasuhiko Tabata,et al.  Significance of release technology in tissue engineering. , 2005, Drug discovery today.

[91]  W R Walsh,et al.  Controlled release of platelet-derived growth factor using ethylene vinyl acetate copolymer (EVAc) coated on stainless-steel wires. , 1995, Biomaterials.

[92]  D. Rifkin,et al.  The extracellular regulation of growth factor action. , 1992, Molecular biology of the cell.

[93]  Willi Paul,et al.  Ceramic Drug Delivery: A Perspective , 2003, Journal of biomaterials applications.

[94]  Salman Rahman,et al.  Novel Vascular Endothelial Growth Factor Binding Domains of Fibronectin Enhance Vascular Endothelial Growth Factor Biological Activity , 2002, Circulation research.

[95]  Wim E Hennink,et al.  Biodegradable dextran hydrogels for protein delivery applications , 2007, Expert review of medical devices.

[96]  Balaji Narasimhan,et al.  Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism. , 2006, Journal of biomedical materials research. Part A.

[97]  W. Mark Saltzman,et al.  Building drug delivery into tissue engineering design , 2002, Nature Reviews Drug Discovery.

[98]  Balaji Narasimhan,et al.  Amphiphilic polyanhydrides for protein stabilization and release. , 2007, Biomaterials.

[99]  Robert Langer,et al.  Controlled Delivery Systems for Proteins Using Polyanhydride Microspheres , 1993, Pharmaceutical Research.

[100]  Nicholas A Peppas,et al.  Molecular imprinting within hydrogels. , 2002, Advanced drug delivery reviews.

[101]  Wei Liu,et al.  Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation. , 2007, International journal of pharmaceutics.

[102]  Samuel I Stupp,et al.  Self-assembling peptide amphiphile nanofiber matrices for cell entrapment. , 2005, Acta biomaterialia.

[103]  A. Spicer,et al.  Hyaluronan: a multifunctional, megaDalton, stealth molecule. , 2000, Current opinion in cell biology.

[104]  J. Benoit,et al.  Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons. , 2000, Biomaterials.

[105]  T. Miyata,et al.  Biomolecule-sensitive hydrogels. , 2002, Advanced drug delivery reviews.

[106]  Bjorn R. Olsen,et al.  Collagens as organizers of extracellular matrix during morphogenesis , 1996 .

[107]  David J Mooney,et al.  Engineering vascular networks in porous polymer matrices. , 2002, Journal of biomedical materials research.

[108]  Robert Langer,et al.  Multi-pulse drug delivery from a resorbable polymeric microchip device , 2003, Nature materials.

[109]  J. A. Hubbell,et al.  The selective modulation of endothelial cell mobility on RGD peptide containing surfaces by YIGSR peptides. , 2005, Biomaterials.

[110]  Alan C. Rapraeger,et al.  Syndecan-Regulated Receptor Signaling , 2000, The Journal of cell biology.

[111]  Alyssa Panitch,et al.  Influence of cross-linked hyaluronic acid hydrogels on neurite outgrowth and recovery from spinal cord injury. , 2007, Journal of neurosurgery. Spine.

[112]  Dwayne G Stupack,et al.  ECM Remodeling Regulates Angiogenesis: Endothelial Integrins Look for New Ligands , 2002, Science's STKE.

[113]  Suna Choi,et al.  Control of Blood Glucose by Novel GLP-1 Delivery Using Biodegradable Triblock Copolymer of PLGA-PEG-PLGA in Type 2 Diabetic Rats , 2004, Pharmaceutical Research.

[114]  Jussi Taipale,et al.  Growth factors in the extracellular matrix , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[115]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[116]  Antonios G Mikos,et al.  Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. , 2002, Journal of biomedical materials research.

[117]  Ivan Stamenkovic,et al.  Functional structure and composition of the extracellular matrix , 2003, The Journal of pathology.

[118]  Robert Langer,et al.  Controlled‐release of IGF‐I and TGF‐β1 in a photopolymerizing hydrogel for cartilage tissue engineering , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[119]  Isao Shinohara,et al.  Glucose Induced Permeation Control of Insulin through a Complex Membrane Consisting of Immobilized Glucose Oxidase and a Poly(amine) , 1984 .

[120]  Antonios G Mikos,et al.  Injectable matrices and scaffolds for drug delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[121]  W. Saltzman,et al.  Surface-mediated gene transfer from nanocomposites of controlled texture , 2004, Nature materials.

[122]  Alastair Forbes,et al.  In vivo characterisation of a novel bioresorbable poly(lactide-co-glycolide) tubular foam scaffold for tissue engineering applications , 2004, Journal of materials science. Materials in medicine.

[123]  B. Gumbiner,et al.  Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis , 1996, Cell.

[124]  R Langer,et al.  Prospects for organ and tissue replacement. , 2001, JAMA.

[125]  Kristi S Anseth,et al.  Controlled release from crosslinked degradable networks. , 2002, Critical reviews in therapeutic drug carrier systems.

[126]  Richard L. Dunn,et al.  Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant , 2000, AAPS PharmSciTech.

[127]  G. Vunjak‐Novakovic,et al.  Engineering complex tissues. , 2006, Tissue engineering.

[128]  David J Mooney,et al.  Cell instructive polymers. , 2006, Advances in biochemical engineering/biotechnology.

[129]  G F Pierce,et al.  Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model. , 2000, The Journal of surgical research.

[130]  N. Peppas,et al.  Hydrogels in Pharmaceutical Formulations , 1999 .

[131]  M. Pishko,et al.  Release of protein from highly cross-linked hydrogels of poly(ethylene glycol) diacrylate fabricated by UV polymerization. , 2001, Biomaterials.

[132]  J. Mcgregor,et al.  ReGel® Polymer-based Delivery of Interleukin-2 as a Cancer Treatment , 2006, Journal of immunotherapy.

[133]  E. Sachlos,et al.  Making tissue engineering scaffolds work. Review: the application of solid freeform fabrication technology to the production of tissue engineering scaffolds. , 2003, European cells & materials.

[134]  Wenlei Jiang,et al.  Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. , 2005, Advanced drug delivery reviews.

[135]  R K Gupta,et al.  Pulsed controlled-released system for potential use in vaccine delivery. , 1996, Journal of pharmaceutical sciences.

[136]  J. Schalkwijk,et al.  Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. , 2007, Biomaterials.

[137]  J. Mestecky,et al.  Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[138]  Wei Sun,et al.  Computer‐aided tissue engineering: overview, scope and challenges , 2004, Biotechnology and applied biochemistry.

[139]  E Ruoslahti,et al.  Molecular and biological interactions of fibronectin. , 1982, The Journal of investigative dermatology.

[140]  S Jockenhoevel,et al.  Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[141]  Elad Katz,et al.  The extracellular matrix as an adhesion checkpoint for mammary epithelial function , 2007, The international journal of biochemistry & cell biology.

[142]  K. Shakesheff,et al.  Polymer carriers for drug delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[143]  Philip R. Kuhl,et al.  Tethered epidermal growth factor as a paradigm for growth factor–induced stimulation from the solid phase , 1996, Nature Medicine.

[144]  Wim E Hennink,et al.  Semisolid, self-catalyzed poly(ortho ester)s as controlled-release systems: protein release and protein stability issues. , 2002, Journal of pharmaceutical sciences.

[145]  David J Mooney,et al.  Synthetic extracellular matrices for tissue engineering and regeneration. , 2004, Current topics in developmental biology.

[146]  J L Cleland,et al.  Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing response. , 1998, Journal of pharmaceutical sciences.

[147]  J L Cleland,et al.  Development of a single-shot subunit vaccine for HIV-1. , 1997, AIDS research and human retroviruses.

[148]  E. Edelman,et al.  Cellular Response to Transforming Growth Factor-β1 and Basic Fibroblast Growth Factor Depends on Release Kinetics and Extracellular Matrix Interactions* , 1996, The Journal of Biological Chemistry.

[149]  Dietmar W. Hutmacher,et al.  Scaffold design and fabrication technologies for engineering tissues — state of the art and future perspectives , 2001, Journal of biomaterials science. Polymer edition.

[150]  David J Mooney,et al.  Protein-based signaling systems in tissue engineering. , 2003, Current opinion in biotechnology.

[151]  M J Yaszemski,et al.  Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. , 2000, Journal of biomedical materials research.

[152]  W. Hennink,et al.  Controlled release of a model protein from enzymatically degrading dextran microspheres. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[153]  V. Sinha,et al.  Biodegradable microspheres for protein delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[154]  Shyni Varghese,et al.  Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration. , 2007, Nature materials.

[155]  C. Bowman,et al.  Mechanical properties of hydrogels and their experimental determination. , 1996, Biomaterials.

[156]  R. Legeros,et al.  Properties of osteoconductive biomaterials: calcium phosphates. , 2002, Clinical orthopaedics and related research.

[157]  M. Brenner,et al.  Controlled release of nerve growth factor enhances sciatic nerve regeneration , 2003, Experimental Neurology.

[158]  Robert Gurny,et al.  Poly(ortho esters): synthesis, characterization, properties and uses. , 2002, Advanced drug delivery reviews.

[159]  T. Jessell,et al.  Diversity and Pattern in the Developing Spinal Cord , 1996, Science.

[160]  J. Hubbell,et al.  Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.

[161]  T. Kissel,et al.  Biodegradable microspheres containing influenza A vaccine: immune response in mice. , 1999, Vaccine.

[162]  D. Mooney,et al.  Hydrogels for tissue engineering. , 2001, Chemical Reviews.

[163]  Laura Indolfi,et al.  Microsphere-integrated collagen scaffolds for tissue engineering: effect of microsphere formulation and scaffold properties on protein release kinetics. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[164]  Xiaofeng Cui,et al.  Application of inkjet printing to tissue engineering , 2006, Biotechnology journal.

[165]  R F Valentini,et al.  Human osteoblast response in vitro to platelet-derived growth factor and transforming growth factor-beta delivered from controlled-release polymer rods. , 1997, Biomaterials.

[166]  Donald L. Wise,et al.  Handbook of Pharmaceutical Controlled Release Technology , 2000 .

[167]  Stefaan C. De Smedt,et al.  “Programmed Polymeric Devices” for Pulsed Drug Delivery , 2004, Pharmaceutical Research.

[168]  Abraham J Domb,et al.  Polyanhydrides: an overview. , 2002, Advanced drug delivery reviews.

[169]  David J. Mooney,et al.  Microenvironmental regulation of biomacromolecular therapies , 2007, Nature Reviews Drug Discovery.

[170]  Steven M. Dinh,et al.  Electronically controlled drug delivery , 1998 .

[171]  L. Debelle,et al.  The structures of elastins and their function. , 1999, Biochimie.

[172]  J L Cleland,et al.  Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[173]  Ge Zhang,et al.  Matrices and scaffolds for drug delivery in vascular tissue engineering. , 2007, Advanced drug delivery reviews.

[174]  Allan S Hoffman,et al.  Hydrogels for biomedical applications. , 2002, Advanced drug delivery reviews.